These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32243615)
1. LncRNA XLOC_003810 promotes T cell activation and inhibits PD-1/PD-L1 expression in patients with myasthenia gravis-related thymoma. Hu B; Niu L; Jiang Z; Xu S; Hu Y; Cao K Scand J Immunol; 2020 Jul; 92(1):e12886. PubMed ID: 32243615 [TBL] [Abstract][Full Text] [Related]
2. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma. Niu L; Jiang J; Yin Y; Hu B Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):989-996. PubMed ID: 32048308 [TBL] [Abstract][Full Text] [Related]
3. Altered naive CD4 Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546 [TBL] [Abstract][Full Text] [Related]
4. Thymus, thymoma, and specific T cells in myasthenia gravis. Beeson D; Bond AP; Corlett L; Curnow SJ; Hill ME; Jacobson LW; MacLennan C; Meager A; Moody AM; Moss P; Nagvekar N; Newsom-Davis J; Pantic N; Roxanis I; Spack EG; Vincent A; Willcox N Ann N Y Acad Sci; 1998 May; 841():371-87. PubMed ID: 9668262 [No Abstract] [Full Text] [Related]
5. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells. Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506 [TBL] [Abstract][Full Text] [Related]
6. Thymoma-associated myasthenia gravis: On the search for a pathogen signature. Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286 [TBL] [Abstract][Full Text] [Related]
7. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312 [TBL] [Abstract][Full Text] [Related]
8. Role of miRNAs in Normal and Myasthenia Gravis Thymus. Cron MA; Guillochon É; Kusner L; Le Panse R Front Immunol; 2020; 11():1074. PubMed ID: 32587589 [TBL] [Abstract][Full Text] [Related]
9. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. Luther C; Poeschel S; Varga M; Melms A; Tolosa E J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045 [TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach. Berardi R; Goteri G; Brunelli A; Pagliaretta S; Paolucci V; Caramanti M; Rinaldi S; Refai M; Pompili C; Morgese F; Torniai M; Marcantognini G; Ricci G; Mazzanti P; Onofri A; Bianchi F; Sabbatini A; Cascinu S Expert Opin Ther Targets; 2020 Sep; 24(9):937-943. PubMed ID: 32662701 [TBL] [Abstract][Full Text] [Related]
11. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis. Altınönder İ; Kaya M; Yentür SP; Çakar A; Durmuş H; Yegen G; Özkan B; Parman Y; Sawalha AH; Saruhan-Direskeneli G J Neuroinflammation; 2024 May; 21(1):126. PubMed ID: 38734662 [TBL] [Abstract][Full Text] [Related]
12. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261 [TBL] [Abstract][Full Text] [Related]
14. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma. Fujii Y; Hayakawa M; Nakahara K J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308 [TBL] [Abstract][Full Text] [Related]
15. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells. Fujii Y; Hayakawa M; Inada K; Nakahara K Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007 [TBL] [Abstract][Full Text] [Related]
16. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus. Marchevsky AM; Walts AE Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267 [TBL] [Abstract][Full Text] [Related]
17. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related]
18. Correlation of thymic pathology with HLA in myasthenia gravis. Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374 [TBL] [Abstract][Full Text] [Related]
19. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Reinhardt C; Melms A Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443 [TBL] [Abstract][Full Text] [Related]
20. Thymic lymphocytes in myasthenia gravis. Birnbaum G; Tsairis P Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]